Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Eli Lilly & CO Transaction History
Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.
- $467 Million
- Q2 2024
A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 1,045 shares of LLY stock, worth $944,241. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,045
Previous 420
148.81%
Holding current value
$944,241
Previous $326,000
190.18%
% of portfolio
0.2%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
3,901Shares Held
765MCall Options Held
6.35MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$87.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$66.7 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.4 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30.6 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $859B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...